684 related articles for article (PubMed ID: 34486829)
1. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
J Rheumatol; 2022 May; 49(5):523-530. PubMed ID: 35105713
[TBL] [Abstract][Full Text] [Related]
3. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care.
Syed U; Subramanian A; Wraith DC; Lord JM; McGee K; Ghokale K; Nirantharakumar K; Haroon S
BMC Med; 2023 Sep; 21(1):363. PubMed ID: 37735654
[TBL] [Abstract][Full Text] [Related]
4. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
[TBL] [Abstract][Full Text] [Related]
5. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases.
Khan R; Kuenzig ME; Tang F; Im JHB; Widdifield J; McCurdy JD; Kaplan GG; Benchimol EI
JAMA Netw Open; 2023 Oct; 6(10):e2337020. PubMed ID: 37812417
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
Widdifield J; Eder L; Chen S; Kwong JC; Hitchon C; Lacaille D; Aviña-Zubieta JA; Svenson LW; Bernatsky S
J Rheumatol; 2022 May; 49(5):531-536. PubMed ID: 35034001
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID study.
Geldof J; Truyens M; Sabino J; Ferrante M; Lambert J; Lapeere H; Hillary T; Van Laethem A; de Vlam K; Verschueren P; Padalko E; Lobaton T; Vermeire S
Front Immunol; 2023; 14():1126351. PubMed ID: 36936974
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
9. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study.
Attauabi M; Poulsen A; Theede K; Pedersen N; Larsen L; Jess T; Rosager Hansen M; Verner-Andersen MK; V Haderslev K; Berg Lødrup A; Molazahi A; Neumann A; Wase A; Seidelin JB; Burisch J
J Crohns Colitis; 2021 Apr; 15(4):540-550. PubMed ID: 33035299
[TBL] [Abstract][Full Text] [Related]
11. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z; Brenner EJ; Mahil SK; Dand N; Yiu ZZN; Yates M; Ungaro RC; Zhang X; Agrawal M; Colombel JF; Gianfrancesco MA; Hyrich KL; Strangfeld A; Carmona L; Mateus EF; Lawson-Tovey S; Klingberg E; Cuomo G; Caprioli M; Cruz-Machado AR; Mazeda Pereira AC; Hasseli R; Pfeil A; Lorenz HM; Hoyer BF; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Seet AM; Al Emadi S; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Isnardi CA; Quintana R; Soriano ER; Hsu TY; D'Silva KM; Sparks JA; Patel NJ; Xavier RM; Marques CDL; Kakehasi AM; Flipo RM; Claudepierre P; Cantagrel A; Goupille P; Wallace ZS; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Griffiths CEM; Barker JN; Smith CH; Yazdany J; Kappelman MD; ;
JAMA Netw Open; 2021 Oct; 4(10):e2129639. PubMed ID: 34661663
[TBL] [Abstract][Full Text] [Related]
12. Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases.
Blaney C; Sommer J; El-Gabalawy R; Bernstein C; Walld R; Hitchon C; Bolton J; Sareen J; Patten S; Singer A; Lix L; Katz A; Fisk J; Marrie RA;
Epidemiol Psychiatr Sci; 2020 Jan; 29():e84. PubMed ID: 31915099
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares.
Carubbi F; Alunno A; Santilli J; Natali L; Mancini B; Di Gregorio N; Del Pinto R; Viscido A; Grassi D; Ferri C
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36282905
[TBL] [Abstract][Full Text] [Related]
14. Impact of immunosuppressive therapy on SARS-CoV-2 mRNA vaccine effectiveness in patients with immune-mediated inflammatory diseases: a Danish nationwide cohort study.
Elmahdi R; Ward D; Ernst MT; Poulsen G; Hallas J; Pottegård A; Jess T
BMJ Open; 2024 Feb; 14(2):e077408. PubMed ID: 38387988
[TBL] [Abstract][Full Text] [Related]
15. Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis.
Widdifield J; Kwong JC; Chen S; Eder L; Benchimol EI; Kaplan GG; Hitchon C; Aviña-Zubieta JA; Lacaille D; Chung H; Bernatsky S
Lancet Rheumatol; 2022 Jun; 4(6):e430-e440. PubMed ID: 35441151
[TBL] [Abstract][Full Text] [Related]
16. Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
Epidemiol Psychiatr Sci; 2019 Jun; 28(3):333-342. PubMed ID: 29098977
[TBL] [Abstract][Full Text] [Related]
17. Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.
Shukla P; Russell MW; Muste JC; Shaia JK; Kumar M; Nowacki AS; Hajj-Ali RA; Singh RP; Talcott KE
Ophthalmol Retina; 2024 Feb; ():. PubMed ID: 38320691
[TBL] [Abstract][Full Text] [Related]
18. Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study.
Belleudi V; Rosa AC; Poggi FR; Armuzzi A; Nicastri E; Goletti D; Diamanti AP; Davoli M; Agabiti N; Addis A
J Clin Med; 2021 May; 10(11):. PubMed ID: 34071452
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough SARS-CoV-2 Infections in Patients With Immune-Mediated Disease Undergoing B Cell-Depleting Therapy: A Retrospective Cohort Analysis.
Calabrese CM; Kirchner E; Husni EM; Moss BP; Fernandez AP; Jin Y; Calabrese LH
Arthritis Rheumatol; 2022 Dec; 74(12):1906-1915. PubMed ID: 35791921
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.
Finckh A; Ciurea A; Raptis CE; Rubbert-Roth A
J Infect Dis; 2023 Aug; 228(Suppl 1):S13-S23. PubMed ID: 37539758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
